Adrenergic nervous system in heart failure: pathophysiology and therapy

A Lymperopoulos, G Rengo, WJ Koch - Circulation research, 2013 - Am Heart Assoc
Heart failure (HF), the leading cause of death in the western world, develops when a cardiac
injury or insult impairs the ability of the heart to pump blood and maintain tissue perfusion. It …

The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications

F Triposkiadis, G Karayannis, G Giamouzis… - Journal of the American …, 2009 - jacc.org
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers
countermeasures aimed to restore cardiac output. These responses are compensatory at …

[HTML][HTML] Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

JA Borovac, D D'Amario, J Bozic… - World journal of …, 2020 - ncbi.nlm.nih.gov
Heart failure (HF) is a complex clinical syndrome characterized by the activation of at least
several neurohumoral pathways that have a common role in maintaining cardiac output and …

Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease

A Ahles, S Engelhardt, PA Insel - Pharmacological reviews, 2014 - Elsevier
The human genome encodes nine different adrenoceptor genes. These are grouped into
three families, namely, the α 1-, α 2-, and β-adrenoceptors, with three family members each …

β-Adrenergic receptor, an essential target in cardiovascular diseases

DC Ali, M Naveed, A Gordon, F Majeed, M Saeed… - Heart failure …, 2020 - Springer
Abstract β-Adrenergic receptors (βARs) belong to a large family of cell surface receptors
known as G protein–coupled receptors (GPCRs). They are coupled to Gs protein (Gαs) for …

MiR-133b as a crucial regulator of TCS-induced cardiotoxicity via activating β-adrenergic receptor signaling pathway in zebrafish embryos

X Wan, H Wang, Q Qian, J Yan - Environmental Pollution, 2023 - Elsevier
As a commonly used antibacterial agent in daily consumer products, triclosan (TCS) has
attracted significant attention due to its potential environmental risks. In this study, we …

Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions

JA Johnson, SB Liggett - Clinical Pharmacology & Therapeutics, 2011 - Wiley Online Library
G‐protein‐coupled receptors (GPCRs) are the targets for many drugs, and genetic variation
in coding and noncoding regions is apparent in many such receptors. In this superfamily …

Clinical and genetic modifiers of long-term survival in heart failure

S Cresci, RJ Kelly, TP Cappola, A Diwan… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to identify genetic modifiers of β-blocker response and long-
term survival in heart failure (HF). Background: Differences in β-blocker treatment effect …

Precision cardiovascular medicine: state of genetic testing

JR Giudicessi, IJ Kullo, MJ Ackerman - Mayo Clinic Proceedings, 2017 - Elsevier
In the 15 years following the release of the first complete human genome sequences, our
understanding of rare and common genetic variation as determinants of cardiovascular …

Cardiovascular pharmacogenomics

DM Roden, JA Johnson, SE Kimmel… - Circulation …, 2011 - Am Heart Assoc
Patients vary in their responses to drug therapy, and some of that variability is genetically
determined. This review outlines general approaches used to identify genetic variation that …